Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas

Clinical Neuropathology

Volumn 24, Issue 5, 2005, Pages 219-224

  Ozen O ^a   Demirhan, B ^a   Altinors N ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Brain invasion; Meningioma; MIB 1 labeling index; p53 immunoreactivity

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR BIOPSY;

ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 24644451509     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmerl, Kloth S, Brandt E, Flad HD 1991 Immunobiochemical and molecularbiologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138: 867-873
2. Gursan N, Gundogdu C, Albayrak A, Kabalar ME 2002 Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas. Int J Neurosci 772: 463-470
3. Kallio M, Sankila R, Hakulinen T, Jaaskelainen J 1992 Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 31: 2-12
4. Karamitopoulou E, Perentes E, Tolnay M, Probst A 1998 Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas. Hum Pathol 29: 140-145
5. Kolles H, Niedermayer I, Schmitt C, Henn W, Feld R, Steudel WI, Zang KD, Feiden W 1995 Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Acta Neurochir (Wien) 137: 174-181
6. Konstantinidou AE, Pavlopoulos PM, Patsouris E, Kaklamanis L, Davaris P 1998 Expression of apoptotic and proliferation markers in meningiomas. J Pathol 186: 325-330
7. Konstantinidou A, Korkolopoulou P, Patsouris E, Mahera H, Hranioti S, Kotsiakis X, Davaris P 2001 Apoptosis detected with monoclonal antibody to single-stranded DNA is a predictor of recurrence in intracranial meningiomas. J Neurooncol 55: 1-9
8. Louis DN, Scheithauer B W, Budka H, von Deimling A, Kepes JJ 2000 Meningiomas. In: Kleihues P, Cavenee WK (eds) WHO Classification of Tumors. Pathology and Genetics in Tumours of the Nervous System. IARC Press, Lyon, pp 176-185
9. Matsuno A, Nagashima T, Matsuura R, Tanaka H, Hirakawa M, Murakami M, Tamura A, Kirino T 1996 Correlation between MIB-1 staining index and the immunoreactivity of p53 protein in recurrent and non-recurrent meningiomas. Am J Clin Pathol 106: 776-781
10. Nakasu S, Li DH, Okabe H, Nakajima M, Matsuda M 2001 Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods. Am J Surg Pathol 25: 472-478
11. Ohkoudo M, Sawa H, Hara M, Saruta K, Also T, Ohki R, Yamamoto H, Maemura E, Shiina Y, Fujii M, Saito I 1998 Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomas. J Neurooncol 38: 41-49
12. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM 1997 Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 21: 1455-1465
13. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM 1998 The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82: 2262-2269
14. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC 1999 "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85: 2046-2056
15. Shibuya M, Ito S, Miwa T, Davis RL, Wilson CB, Hoshino T1993 Proliferative potential of brain tumors. Analyses with Ki-67 and anti-DNApolymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nuclear organizer region counts. Cancer 71: 199-206
16. Simpson D 1957 The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20: 22-39
17. Stafford SL, Perry A, Suman VJ, Meyer FB, Scheithauer BW, Lohse CM, Shaw EG 1998 Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients 1978 through 1988. Mayo Clin Proc 73: 936-942
18. Wang JL, Zhang ZJ, Hartman M, Smits A, Westermark B, Muhr C, Nister M 1995 Detection of TP53 gene mutation in human meningiomas: a study using immunohistochemistry, polymerase chain reaction/single-strand conformation polymorphism and DNA sequencing techniques on paraffin-embedded samples. Int J Cancer 64: 223-228